Two cases demonstrate an association between Tropheryma whipplei and pulmonary marginal zone lymphoma.
Achromobacter xylosoxidans
Tropheryma whipplei
Antibiotics
MALT lymphoma
Metagenomics whole genome sequencing
Pulmonary marginal zone lymphoma
Pulmonary microenvironment
Whipple’s disease
Journal
Infectious agents and cancer
ISSN: 1750-9378
Titre abrégé: Infect Agent Cancer
Pays: England
ID NLM: 101276559
Informations de publication
Date de publication:
27 Jul 2024
27 Jul 2024
Historique:
received:
06
04
2024
accepted:
15
07
2024
medline:
28
7
2024
pubmed:
28
7
2024
entrez:
27
7
2024
Statut:
epublish
Résumé
Marginal zone lymphomas of mucosa-associated lymphatic tissues (MZL of MALT) are a group of indolent B-cell neoplasms, which are thought to arise from chronic antigenic stimulation of B-cells either due to underlying chronic infection or autoimmune disease. Little is known about potential causative pathogens in pulmonary MZL (PMZL), although some data suggests a potential role of Achromobacter (A.) xylosoxidans. An index case of chronic pulmonary colonisation with Tropheryma (T.) whipplei and subsequent development of PMZL was identified by T. whipplei specific PCR and metagenomic next genome sequencing (mNGS). This case prompted a retrospectively conducted analysis of T. whipplei-specific PCRs in lung tissue from PMZL patients (n = 22), other pulmonary lymphomas, and normal controls. Positive results were confirmed by mNGS. A systematic search for T. whipplei and A. xylosoxidans in our in-house mNGS dataset comprising autopsy lungs, lung biopsies and lung resection specimens (n = 181) was subsequently performed. A 69-year-old patient presented with weight loss and persistent pulmonary consolidation. Subsequent mNGS analysis detected T. whipplei in the resected lung specimen. An antibiotic regimen eventually eliminated the bacterium. However, the consolidation persisted, and the diagnosis of PMZL was made in a second lung resection specimen. A second case of T. whipplei-associated PMZL was subsequently detected in the retrospectively analysed PMZL cohort. Both cases showed comparatively few mutations and no mutations in genes encoding for NF-κB pathway components, suggesting that T. whipplei infection may substitute for mutations in these PMZL. None of the samples in our in-house dataset tested positive for T. whipplei. In contrast, A. xylosoxidans was frequently found in both autopsy lungs and lung biopsy / resection specimens that were not affected by PMZL (> 50%). Our data suggests that T. whipplei colonisation of lungs may trigger PMZL as a potential driver. Systematic analyses with larger cohorts should be conducted to further support this hypothesis. The frequent detection of A. xylosoxidans in lung tissue suggests that it is a common component of the pulmonary microbiome and therefore less likely to trigger lymphomas.
Sections du résumé
BACKGROUND
BACKGROUND
Marginal zone lymphomas of mucosa-associated lymphatic tissues (MZL of MALT) are a group of indolent B-cell neoplasms, which are thought to arise from chronic antigenic stimulation of B-cells either due to underlying chronic infection or autoimmune disease. Little is known about potential causative pathogens in pulmonary MZL (PMZL), although some data suggests a potential role of Achromobacter (A.) xylosoxidans.
METHODS
METHODS
An index case of chronic pulmonary colonisation with Tropheryma (T.) whipplei and subsequent development of PMZL was identified by T. whipplei specific PCR and metagenomic next genome sequencing (mNGS). This case prompted a retrospectively conducted analysis of T. whipplei-specific PCRs in lung tissue from PMZL patients (n = 22), other pulmonary lymphomas, and normal controls. Positive results were confirmed by mNGS. A systematic search for T. whipplei and A. xylosoxidans in our in-house mNGS dataset comprising autopsy lungs, lung biopsies and lung resection specimens (n = 181) was subsequently performed.
RESULTS
RESULTS
A 69-year-old patient presented with weight loss and persistent pulmonary consolidation. Subsequent mNGS analysis detected T. whipplei in the resected lung specimen. An antibiotic regimen eventually eliminated the bacterium. However, the consolidation persisted, and the diagnosis of PMZL was made in a second lung resection specimen. A second case of T. whipplei-associated PMZL was subsequently detected in the retrospectively analysed PMZL cohort. Both cases showed comparatively few mutations and no mutations in genes encoding for NF-κB pathway components, suggesting that T. whipplei infection may substitute for mutations in these PMZL. None of the samples in our in-house dataset tested positive for T. whipplei. In contrast, A. xylosoxidans was frequently found in both autopsy lungs and lung biopsy / resection specimens that were not affected by PMZL (> 50%).
CONCLUSIONS
CONCLUSIONS
Our data suggests that T. whipplei colonisation of lungs may trigger PMZL as a potential driver. Systematic analyses with larger cohorts should be conducted to further support this hypothesis. The frequent detection of A. xylosoxidans in lung tissue suggests that it is a common component of the pulmonary microbiome and therefore less likely to trigger lymphomas.
Identifiants
pubmed: 39068468
doi: 10.1186/s13027-024-00597-0
pii: 10.1186/s13027-024-00597-0
doi:
Types de publication
Journal Article
Langues
eng
Pagination
33Subventions
Organisme : Krebsliga Schweiz
ID : KFS-5228-02-2021
Informations de copyright
© 2024. The Author(s).
Références
De Martel C, Georges D, Bray F, Ferlay J, Clifford GM. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2020;8:e180–90.
pubmed: 31862245
doi: 10.1016/S2214-109X(19)30488-7
Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.
pubmed: 26980727
pmcid: 4874220
doi: 10.1182/blood-2016-01-643569
Troppan K, Wenzl K, Neumeister P, Deutsch A. Molecular Pathogenesis of MALT Lymphoma. Gastroenterol Res Pract. 2015;2015:1–10.
doi: 10.1155/2015/102656
Rossi D, Bertoni F, Zucca E. Marginal-Zone Lymphomas. N Engl J Med. 2022;386:568–81.
pubmed: 35139275
doi: 10.1056/NEJMra2102568
Hu Q, Zhang Y, Zhang X, Fu K. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori infection: a review of current diagnosis and management. Biomark Res. 2016;4:15.
pubmed: 27468353
pmcid: 4962427
doi: 10.1186/s40364-016-0068-1
Köller MC, Aigelsreiter A. Chlamydia psittaci in ocular adnexal MALT lymphoma: a possible causative agent in the pathogenesis of this disease. Curr Clin Micro Rpt. 2018;5:261–7.
doi: 10.1007/s40588-018-0108-8
Travaglino A, Varricchio S, Pace M, Russo D, Picardi M, Baldo A, et al. Borrelia burgdorferi in primary cutaneous lymphomas: a systematic review and meta-analysis. J Deutsche Derma Gesell. 2020;18:1379–84.
Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107:3034–44.
pubmed: 16397126
doi: 10.1182/blood-2005-09-3679
Adam P, Czapiewski P, Colak S, Kosmidis P, Tousseyn T, Sagaert X, et al. Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe. Br J Haematol. 2014;164:804–10.
pubmed: 24372375
doi: 10.1111/bjh.12703
Borie R, Wislez M, Antoine M, Copie-Bergman C, Thieblemont C, Cadranel J. Pulmonary mucosa-associated lymphoid tissue lymphoma revisited. Eur Respir J. 2016;47:1244–60.
pubmed: 26797028
doi: 10.1183/13993003.01701-2015
Fenollar F, Lagier J-C, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–12.
pubmed: 24877762
doi: 10.1016/j.jinf.2014.05.008
Martinetti M, Biagi F, Badulli C, Feurle GE, Müller C, Moos V, et al. The HLA Alleles DRB1*13 and DQB1*06 Are Associated to Whipple’s Disease. Gastroenterology. 2009;136:2289–94.
pubmed: 19208355
doi: 10.1053/j.gastro.2009.01.051
Schöniger-Hekele M, Petermann D, Weber B, Müller C. Tropheryma whipplei in the environment: survey of sewage plant influxes and sewage plant workers. Appl Environ Microbiol. 2007;73:2033–5.
pubmed: 17277223
pmcid: 1828826
doi: 10.1128/AEM.02335-06
Dolmans RAV, Boel CHE, Lacle MM, Kusters JG. Clinical manifestations, treatment, and diagnosis of tropheryma whipplei infections. Clin Microbiol Rev. 2017;30:529–55.
pubmed: 28298472
pmcid: 5355640
doi: 10.1128/CMR.00033-16
Ruffer N, Holzer M-T, Gkanatsas Y, Schinglerová I, Boro D, Krusche M, et al. Chronische tropheryma-whipplei-infektion: eine wichtige Differentialdiagnose der therapierefraktären Polyarthritis. Z Rheumatol. 2023;82:885–91.
pubmed: 35384513
doi: 10.1007/s00393-022-01194-5
Jutant E-M, Roche A, Boucly A, Camboulive A, Jevnikar M, Jais X, et al. Whipple’s disease: a rare and life-threatening cause of pulmonary hypertension. Pulmonary hypertension [Internet]. European Respiratory Society; 2021 [cited 2023 Dec 29]. p. PA3599. Available from: http://erj.ersjournals.com/lookup/doi/ https://doi.org/10.1183/13993003.congress-2021.PA3599
Gillen CD, Coddington R, Monteith PG, Taylor RH. Extraintestinal lymphoma in association with Whipple’s disease. Gut. 1993;34:1627–9.
pubmed: 7694890
pmcid: 1374435
doi: 10.1136/gut.34.11.1627
Gruner U, Goesch P, Donner A, Peters U. Morbus Whipple und Non-Hodgkin-Lymphom. Z Gastroenterol. 2001;39:305–9.
pubmed: 11367979
doi: 10.1055/s-2001-12865
Cadenas F, Sánchez-Lombraña JL, Pérez R, Lomo FJ, Madrigal Rubiales B, Vivas S, et al. Persistent leucocytosis as initial manifestation of Whipple’s disease and development of gastric cancer in the follow up. Rev Esp Enferm Dig. 1999;91:785–8.
pubmed: 10601772
Wang S, Ernst LM, Smith BR, Tallini G, Howe JG, Crouch J, et al. Systemic Tropheryma whippleii infection associated with monoclonal B-cell proliferation: a Helicobacter pylori-type pathogenesis? Arch Pathol Lab Med. 2003;127:1619–22.
pubmed: 14632565
doi: 10.5858/2003-127-1619-STWIAW
Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch. 2022;480:403–13.
pubmed: 34494161
doi: 10.1007/s00428-021-03186-3
Nienhold R, Mensah N, Frank A, Graber A, Koike J, Schwab N, et al. Unbiased screen for pathogens in human paraffin-embedded tissue samples by whole genome sequencing and metagenomics. Frontiers in Cellular and Infection Microbiology [Internet]. 2022 [cited 2024 Jan 6];12. Available from: https://www.frontiersin.org/articles/ https://doi.org/10.3389/fcimb.2022.968135
Talwalkar SS, Valbuena JR, Abruzzo LV, Admirand JH, Konoplev SN, Bueso-Ramos CE, et al. MALT1 gene rearrangements and NF-kappaB activation involving p65 and p50 are absent or rare in primary MALT lymphomas of the breast. Mod Pathol. 2006;19:1402–8.
pubmed: 16917511
doi: 10.1038/modpathol.3800668
Ivanova V-S, Davies J, Menter T, Wild D, Müller A, Krasniqi F, et al. Primary bone diffuse large B-cell lymphoma (PB-DLBCL): a distinct extranodal lymphoma of germinal centre origin, with a common EZB-like mutational profile and good prognosis. Histopathology. 2024;84:525–38.
pubmed: 37965677
doi: 10.1111/his.15096
Vela V, Juskevicius D, Prince SS, Cathomas G, Dertinger S, Diebold J, et al. Deciphering the genetic landscape of pulmonary lymphomas. Mod Pathol. 2021;34:371–9.
pubmed: 32855441
doi: 10.1038/s41379-020-00660-2
Nienhold R, Ciani Y, Koelzer VH, Tzankov A, Haslbauer JD, Menter T, et al. Two distinct immunopathological profiles in autopsy lungs of COVID-19. Nat Commun. 2020;11:5086.
pubmed: 33033248
pmcid: 7546638
doi: 10.1038/s41467-020-18854-2
Sauter C, Kurrer MO. Intracellular bacteria in Hodgkin’s disease and sclerosing mediastinal B-cell lymphoma: Sign of a bacterial etiology? Swiss Med Wkly. 2002;132:312–5.
pubmed: 12362281
Tison A, Preuss P, Leleu C, Robin F, Le Pluart A, Vix J, et al. Rheumatological features of Whipple disease. Sci Rep. 2021;11:12278.
pubmed: 34112875
pmcid: 8192552
doi: 10.1038/s41598-021-91671-9
Crayne CB, Albeituni S, Nichols KE, Cron RQ. The Immunology of Macrophage Activation Syndrome. Frontiers in Immunology [Internet]. 2019 [cited 2023 Dec 26];10. Available from: https://www.frontiersin.org/articles/ https://doi.org/10.3389/fimmu.2019.00119
Desnues B, Ihrig M, Raoult D, Mege J-L. Whipple’s disease: a macrophage disease. Clin Vaccine Immunol. 2006;13:170–8.
pubmed: 16467322
pmcid: 1391942
doi: 10.1128/CVI.13.2.170-178.2006
Lagier J-C, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine (Baltimore). 2010;89:337–45.
pubmed: 20827111
doi: 10.1097/MD.0b013e3181f204a8
Marth T. Tropheryma whipplei, Immunosuppression and whipple’s disease: from a low-pathogenic, environmental infectious organism to a rare. Multifaceted Inflamm Complex Dig Dis. 2015;33:190–9.
Marth T. Complicated Whipple’s disease and endocarditis following tumor necrosis factor inhibitors. World J Cardiol. 2014;6:1278–84.
pubmed: 25548618
pmcid: 4278163
doi: 10.4330/wjc.v6.i12.1278
Liu J, Xiang J, Li X, Blankson S, Zhao S, Cai J, et al. NF-κB activation is critical for bacterial lipoprotein tolerance-enhanced bactericidal activity in macrophages during microbial infection. Sci Rep. 2017;7:40418.
pubmed: 28079153
pmcid: 5227741
doi: 10.1038/srep40418
Thurner L, Hartmann S, Fadle N, Regitz E, Kemele M, Kim Y-J, et al. Lymphocyte predominant cells detect Moraxella catarrhalis-derived antigens in nodular lymphocyte-predominant Hodgkin lymphoma. Nat Commun. 2020;11:2465.
pubmed: 32424289
pmcid: 7235000
doi: 10.1038/s41467-020-16375-6
Mani RS, Amin MA, Li X, Kalyana-Sundaram S, Veeneman BA, Wang L, et al. Inflammation-induced oxidative stress mediates gene fusion formation in prostate cancer. Cell Rep. 2016;17:2620–31.
pubmed: 27926866
pmcid: 5147555
doi: 10.1016/j.celrep.2016.11.019
Serramito-Gómez I, Boada-Romero E, Slowicka K, Vereecke L, Van Loo G, Pimentel-Muiños FX. The anti-inflammatory protein TNFAIP3/A20 binds the WD40 domain of ATG16L1 to control the autophagic response, NFKB/NF-κB activation and intestinal homeostasis. Autophagy. 2019;15:1657–9.
pubmed: 31184523
pmcid: 6693451
doi: 10.1080/15548627.2019.1628549
Ortega-Molina A, Boss IW, Canela A, Pan H, Jiang Y, Zhao C, et al. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development. Nat Med. 2015;21:1199–208.
pubmed: 26366710
pmcid: 4676270
doi: 10.1038/nm.3943
Menter T, Juskevicius D, Alikian M, Steiger J, Dirnhofer S, Tzankov A, et al. Mutational landscape of B-cell post-transplant lymphoproliferative disorders. Br J Haematol. 2017;178:48–56.
pubmed: 28419429
doi: 10.1111/bjh.14633
Zhou Y, Xu Z, Lin W, Duan Y, Lu C, Liu W, et al. Comprehensive genomic profiling of EBV-positive diffuse large b-cell lymphoma and the expression and clinicopathological correlations of some related genes. Front Oncol. 2019;9:683.
pubmed: 31403034
pmcid: 6669985
doi: 10.3389/fonc.2019.00683
Ishimatsu Y, Mukae H, Matsumoto K, Harada T, Hara A, Hara S, et al. Two cases with pulmonary mucosa-associated lymphoid tissue lymphoma successfully treated with clarithromycin. Chest. 2010;138:730–3.
pubmed: 20822996
doi: 10.1378/chest.09-2358
Hernández-Pando R, Jeyanathan M, Mengistu G, Aguilar D, Orozco H, Harboe M, et al. Persistence of DNA from Mycobacterium tuberculosis in superficially normal lung tissue during latent infection. Lancet. 2000;356:2133–8.
pubmed: 11191539
doi: 10.1016/S0140-6736(00)03493-0
Inadome Y, Ikezawa T, Oyasu R, Noguchi M. Malignant lymphoma of bronchus-associated lymphoid tissue (BALT) coexistent with pulmonary tuberculosis. Pathol Int. 2001;51:807–11.
pubmed: 11881735
doi: 10.1046/j.1440-1827.2001.01272.x
Gaur S, Trayner E, Aish L, Weinstein R. Bronchus-associated lymphoid tissue lymphoma arising in a patient with bronchiectasis and chronic Mycobacterium avium infection. Am J Hematol. 2004;77:22–5.
pubmed: 15307101
doi: 10.1002/ajh.20136
Parsonnet J, Hansen S, Rodriguez L, Gelb AB, Warnke RA, Jellum E, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori Infection and Gastric Lymphoma. N Engl J Med. 1994;330(18):1267–71.
pubmed: 8145781
doi: 10.1056/NEJM199405053301803
Raderer M, Wöhrer S, Kiesewetter B, Dolak W, Lagler H, Wotherspoon A, et al. Antibiotic treatment as sole management of Helicobacter pylori-negative gastric MALT lymphoma: a single center experience with prolonged follow-up. Ann Hematol. 2015;94:969–73.
pubmed: 25579756
doi: 10.1007/s00277-014-2298-3
Wotherspoon AC, Doglioni C, Diss TC, Pan L, Moschini A, de Boni M, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet. 1993;342:575–7.
pubmed: 8102719
doi: 10.1016/0140-6736(93)91409-F
Park JB, Koo JS. Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue lymphoma. World J Gastroenterol. 2014;20:2751–9.
pubmed: 24659867
pmcid: 3961970
doi: 10.3748/wjg.v20.i11.2751
Salter SJ, Cox MJ, Turek EM, Calus ST, Cookson WO, Moffatt MF, et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 2014;12:87.
pubmed: 25387460
pmcid: 4228153
doi: 10.1186/s12915-014-0087-z
Simner PJ, Salzberg SL. The human “contaminome” and understanding infectious disease. N Engl J Med. 2022;387:943–6.
pubmed: 36069879
doi: 10.1056/NEJMcibr2208625
Gihawi A, Ge Y, Lu J, Puiu D, Xu A, Cooper CS, et al. Major data analysis errors invalidate cancer microbiome findings. MBio. 2023;14:e0160723.
pubmed: 37811944
doi: 10.1128/mbio.01607-23